Insulin Access and Affordability Working Group: Conclusions and Recommendations

Diabetes Care. 2018 Jun;41(6):1299-1311. doi: 10.2337/dci18-0019. Epub 2018 May 8.

Authors

William T Cefalu¹, Daniel E Dawes², Gina Gavlak³, Dana Goldman⁴, William H Herman⁵, Karen Van Nuys⁴, Alvin C Powers⁶, Simeon I Taylor⁷, Alan L Yatvin⁸; Insulin Access and Affordability Working Group

Affiliations

¹ American Diabetes Association, Arlington, VA wcefalu@diabetes.org.
² Morehouse School of Medicine, Atlanta, GA.
³ North Coast Health, Lakewood, OH.
⁴ USC Schaeffer Center for Health Policy & Economics, Los Angeles, CA.
⁵ University of Michigan, Ann Arbor, MI.
⁶ Vanderbilt University Medical Center, Nashville, TN.
⁷ University of Maryland School of Medicine, Baltimore, MD.
⁸ Popper & Yatvin, Philadelphia, PA.

PMID: 29739814
DOI: 10.2337/dci18-0019

No abstract available

Publication types

Practice Guideline
Research Support, Non-U.S. Gov't
Review

MeSH terms

Diabetes Mellitus / drug therapy*
Diabetes Mellitus / economics
Health Planning Guidelines
Health Services Accessibility* / economics
Humans
Hypoglycemic Agents / economics
Hypoglycemic Agents / supply & distribution
Hypoglycemic Agents / therapeutic use*
Insulins / economics
Insulins / supply & distribution
Insulins / therapeutic use*

Substances

Hypoglycemic Agents
Insulins